-+ 0.00%
-+ 0.00%
-+ 0.00%

CELLDEX THERAPEUTICS SHARES FALL 1.9% AFTER DATA FROM LATE-STAGE TRIALS OF ITS SKIN DISEASE DRUG

Reuters·09/22/2026 13:35:50

Please log in to view news